News & Updates

Three out of five teens with refractory constipation achieve improvements in bowel movement with prucalopride, while having acceptable side effect profiles, as shown in a small study.

Patients with paediatric-onset autoimmune liver disease show slower early immunological and biochemical response to a tacrolimus-based treatment as compared with regimens using prednisolone or azathioprine, reports a study presented at the 2022 Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN 2022).

The combination of brentuximab vedotin (Bv) and chemotherapy was superior to a standard paediatric dose-intensive chemotherapy regimen in boosting event-free survival (EFS) in paediatric patients with high-risk Hodgkin lymphoma (HL), according to the phase III AHOD1331* trial presented at ASCO 2022.

The use of electroencephalogram-based neurofeedback (EEG-NF) can help combat inattention among adolescents and young adults, though its efficacy for controlling hyperactivity or impulsivity remains unestablished, a recent meta-analysis has found.

Paracetamol is as safe and effective as ibuprofen or indomethacin in the treatment of patent ductus arteriosus (PDA) in preterm neonates, suggests a recent study. In addition, use of paracetamol results in fewer adverse effects.